0,979  0,001  Bile acid receptor antagonist
0,969  0,002  TNF expression inhibitor
0,963  0,001  UGT1A4 substrate
0,961  0,001  Cholesterol antagonist
0,961  0,002  Antihypercholesterolemic
0,956  0,003  Chemoprotective
0,951  0,002  UGT1A6 substrate
0,948  0,001  UGT2B1 substrate
0,941  0,001  Phospholipase C inhibitor
0,939  0,003  CYP2C19 substrate
0,933  0,001  UGT1A3 substrate
0,926  0,003  Respiratory analeptic
0,919  0,003  Teratogen
0,911  0,002  NOS3 expression inhibitor
0,912  0,004  Embryotoxic
0,907  0,001  UGT2B4 substrate
0,906  0,001  UGT1A1 substrate
0,898  0,001  Sodium/bile acid cotransporter inhibitor
0,894  0,001  UGT2B7 substrate
0,891  0,003  Analeptic
0,885  0,001  Choleretic
0,888  0,005  CYP3A4 substrate
0,877  0,004  Carcinogenic
0,876  0,004  Caspase 9 stimulant
0,871  0,004  UDP-glucuronosyltransferase substrate
0,863  0,002  Hair growth stimulant
0,865  0,004  Hepatic disorders treatment
0,853  0,005  CYP2C9 substrate
0,845  0,002  Anesthetic general
0,847  0,010  Antiinflammatory
0,839  0,003  Sulfotransferase substrate
0,815  0,004  Bone diseases treatment
0,807  0,003  Proliferative diseases treatment
0,808  0,004  Lipoprotein disorders treatment
0,804  0,004  Metabolic disease treatment
0,794  0,000  Anticholelithogenic
0,792  0,002  Antihyperlipoproteinemic
0,790  0,003  Anesthetic
0,790  0,007  Cyclophilin D inhibitor
0,790  0,007  Antidiabetic
0,780  0,005  Antiosteoporotic
0,766  0,007  Chemopreventive
0,754  0,001  Cholesterol synthesis inhibitor
0,772  0,020  Apoptosis agonist
0,752  0,001  Antipruritic, allergic
0,749  0,002  Retinoprotector
0,758  0,016  Transcription factor NF kappa B inhibitor
0,741  0,005  Atherosclerosis treatment
0,728  0,004  Renal disease treatment
0,710  0,004  Apoptosis antagonist
0,707  0,006  NOS2 expression inhibitor
0,696  0,005  Antipsoriatic
0,701  0,011  Antiobesity
0,675  0,004  Prostatic (benign) hyperplasia treatment
0,672  0,005  Hypolipemic
0,662  0,001  Farnesoid X receptor agonist
0,667  0,008  Cytotoxic
0,656  0,001  5-Alpha-reductase inhibitor
0,658  0,008  Antiepileptic
0,644  0,004  Liver fibrosis treatment
0,644  0,008  Antidiabetic (type 2)
0,633  0,002  Lipocortins synthesis antagonist
0,639  0,010  UGT1A9 substrate
0,630  0,004  Antidiarrheal
0,627  0,004  Hepatoprotectant
0,625  0,002  Antineoplastic, alkylator
0,610  0,003  Liver cirrhosis treatment
0,614  0,009  Inflammatory Bowel disease treatment
0,612  0,012  Immunosuppressant
0,590  0,001  UGT2B9 substrate
0,593  0,007  Angiogenesis stimulant
0,581  0,005  Amyotrophic lateral sclerosis treatment
0,567  0,002  Pregnane X receptor agonist
0,564  0,003  UGT2B15 substrate
0,575  0,017  Sensitization
0,555  0,004  Interferon gamma antagonist
0,553  0,003  Androgen antagonist
0,552  0,005  Diuretic
0,546  0,001  Antipruritic, non-allergic
0,540  0,003  Abortion inducer
0,538  0,002  Farnesoid X receptor antagonist
0,539  0,004  Antiacne
0,541  0,007  Interleukin agonist
0,555  0,022  Immunostimulant
0,549  0,016  Cytostatic
0,531  0,003  Prostate disorders treatment
0,526  0,003  Autism spectrum disorders treatment
0,540  0,031  Antibacterial
0,511  0,004  Antiinfertility, female
0,527  0,019  CTGF expression inhibitor
0,522  0,014  Nitric oxide antagonist
0,508  0,009  Antineoplastic (liver cancer)
0,515  0,019  AR expression inhibitor
0,501  0,005  Contraceptive
0,501  0,008  Muscle relaxant
0,505  0,013  DNA damaging
0,494  0,004  Expectorant
0,493  0,003  Anticataract
0,535  0,047  Antineoplastic (breast cancer)
0,507  0,021  Antifungal
0,492  0,010  Antihypoxic
0,473  0,001  UGT2B10 substrate
0,489  0,020  Antineoplastic (glioma)
0,476  0,014  Antidiabetic symptomatic
0,480  0,025  Radioprotector
0,454  0,001  5-Alpha-reductase 2 inhibitor
0,484  0,031  Antithrombotic
0,464  0,013  Sedative
0,477  0,027  Antineoplastic (melanoma)
0,465  0,018  Antineoplastic (glioblastoma multiforme)
0,458  0,014  Antineoplastic (renal cancer)
0,474  0,031  CYP2C19 inhibitor
0,473  0,031  Antineoplastic (ovarian cancer)
0,468  0,028  Immunomodulator
0,442  0,002  Hyperparathyroidism treatment
0,458  0,019  Hypoxia-inducible factor 1 alpha inhibitor
0,440  0,009  Diabetic retinopathy treatment
0,431  0,001  5-Alpha-reductase 1 inhibitor
0,462  0,039  Prostate cancer treatment
0,441  0,017  Interleukin 2 agonist
0,426  0,004  LDLR expression enhancer
0,439  0,017  Vascular (periferal) disease treatment
0,443  0,025  Cardiovascular analeptic
0,467  0,051  Antineoplastic (lung cancer)
0,462  0,047  Antileukemic
0,419  0,005  DNA polymerase I inhibitor
0,453  0,039  Stroke treatment
0,426  0,015  Wound healing agent
0,414  0,007  Protein kinase stimulant
0,413  0,007  Alkylator
0,409  0,006  Antipruritic
0,418  0,019  Antineoplastic (endocrine cancer)
0,419  0,025  Hypoglycemic
0,399  0,006  Insulin secretagoues
0,421  0,032  ICAM1 expression inhibitor
0,420  0,034  Antineoplastic (pancreatic cancer)
0,423  0,038  Caspase 3 stimulant
0,400  0,015  Antiparkinsonian, rigidity relieving
0,388  0,003  Mucolytic
0,389  0,008  Antiviral (Influenza A)
0,384  0,003  CDC25A inhibitor
0,413  0,033  Antioxidant
0,415  0,036  Antineoplastic (brain cancer)
0,383  0,013  Antiviral (Influenza)
0,395  0,027  Cardiodepressant
0,367  0,004  Contraceptive female
0,384  0,023  Antihypertriglyceridemic
0,409  0,048  Antiallergic
0,386  0,030  Platelet antagonist
0,363  0,008  Neurotrophic factor enhancer
0,354  0,003  Actinic keratosis treatment
0,354  0,003  Paget's disease treatment
0,348  0,003  Androgen agonist
0,351  0,008  Growth factor agonist
0,351  0,010  Diabetic nephropathy treatment
0,386  0,047  CYP2D6 substrate
0,374  0,036  Calcium channel activator
0,338  0,001  Arachidonic acid antagonist
0,355  0,019  Platelet adhesion inhibitor
0,355  0,020  P-glycoprotein inhibitor
0,368  0,035  Antipyretic
0,340  0,007  Antifungal enhancer
0,333  0,001  UGT2B11 substrate
0,347  0,019  Antiviral (Herpes)
0,362  0,034  Mutagenic
0,324  0,005  ABCA1 expression enhancer
0,354  0,045  Antineoplastic (cervical cancer)
0,313  0,005  AMP-activated protein kinase stimulant
0,339  0,040  Antineoplastic (lymphoma)
0,325  0,028  Growth hormone agonist
0,305  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,317  0,023  Gastrin inhibitor
0,307  0,014  Antidote
0,292  0,003  Liver X receptor alpha agonist
0,291  0,002  Glycine receptor agonist
0,309  0,021  Antialcoholic
0,358  0,070  Vasodilator, peripheral
0,295  0,010  Psychosexual dysfunction treatment
0,302  0,019  Protein-tyrosine phosphatase inhibitor
0,295  0,012  Aldehyde dehydrogenase inhibitor
0,306  0,030  RNA-directed DNA polymerase inhibitor
0,274  0,001  Cholesterol absorption inhibitor
0,292  0,019  Amylase inhibitor
0,275  0,003  Hypercalcemia treatment
0,271  0,001  Vitamin D receptor agonist
0,279  0,008  Age-related macular degeneration treatment
0,271  0,000  Ileal bile acid transport inhibitor
0,336  0,066  Antihypertensive
0,277  0,008  Alcohol dehydrogenase substrate
0,272  0,003  Sleep apnea treatment
0,270  0,003  Botulinum neurotoxin type A inhibitor
0,284  0,020  Insulin sensitizer
0,265  0,003  Lanosterol 14 alpha demethylase inhibitor
0,308  0,047  Myocardial infarction treatment
0,284  0,024  Skeletal muscle relaxant
0,275  0,016  Antidiabetic (type 1)
0,267  0,008  SULT1A1 substrate
0,260  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,255  0,001  Na+ K+ transporting ATPase inhibitor
0,317  0,063  Cardioprotectant
0,271  0,019  Interleukin 6 antagonist
0,311  0,059  Antineoplastic (multiple myeloma)
0,261  0,010  Neurotrophic factor
0,288  0,039  Antineoplastic enhancer
0,251  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,255  0,007  Microtubule formation inhibitor
0,284  0,041  EphB2 antagonist
0,262  0,023  Bone formation stimulant
0,296  0,058  Cardiotonic
0,244  0,006  Estrogen receptor alpha antagonist
0,235  0,002  Anabolic
0,234  0,003  Glycine receptor antagonist
0,246  0,015  VEGF expression inhibitor
0,298  0,069  CYP1A2 substrate
0,230  0,003  Carbonic anhydrase IV inhibitor
0,231  0,004  Progesterone antagonist
0,281  0,057  Heart failure treatment
0,234  0,013  Antieczematic
0,225  0,006  Adenylate cyclase stimulant
0,272  0,054  DNA synthesis inhibitor
0,224  0,010  Growth stimulant
0,223  0,009  Hedgehog signaling inhibitor
0,265  0,054  Antiulcerative
0,213  0,003  RNA-directed RNA polymerase stimulant
0,218  0,009  Antineoplastic alkaloid
0,232  0,028  Acute respiratory distress syndrome (ARDS) treatment
0,248  0,048  VCAM1 expression inhibitor
0,299  0,100  Antiprotozoal (Plasmodium)
0,205  0,008  Prolactin inhibitor
0,270  0,075  Huntington's disease treatment
0,246  0,055  Fibrosis treatment
0,193  0,002  Vitamin D receptor antagonist
0,230  0,041  Antiviral (Hepatitis)
0,187  0,001  Hedgehog signaling activator
0,228  0,042  Eye irritation, high
0,256  0,072  Tumour necrosis factor alpha release inhibitor
0,207  0,026  Antiviral (Hepatitis B)
0,246  0,071  Antineoplastic (sarcoma)
0,297  0,126  Antiprotozoal
0,186  0,015  Estrogen antagonist
0,209  0,038  Phospholipase A2 inhibitor
0,179  0,009  Estrogen agonist
0,248  0,078  Antineoplastic (non-small cell lung cancer)
0,177  0,013  Contraceptive male
0,200  0,035  Skin irritative effect
0,168  0,010  Postmenopausal disorders treatment
0,159  0,003  Phospholipase D inhibitor
0,256  0,100  Antineoplastic (colorectal cancer)
0,173  0,017  Chronic obstructive bronchitis treatment
0,159  0,005  CDC25B inhibitor
0,177  0,026  Endometrios treatment
0,194  0,047  Antirickettsial
0,224  0,081  Free radical scavenger
0,218  0,077  Antiviral (HIV)
0,167  0,027  Antineoplastic antibiotic
0,235  0,097  5 Hydroxytryptamine uptake stimulant
0,142  0,004  Glucocorticoid antagonist
0,149  0,013  Aromatase inhibitor
0,163  0,030  GABA receptor agonist
0,132  0,002  Apical sodium codependent bile acid transporter inhibitor
0,145  0,017  Transcription factor NF kappa B stimulant
0,135  0,009  Autotaxin inhibitor
0,230  0,104  Antineoplastic (colon cancer)
0,128  0,003  Lipocortins synthesis agonist
0,132  0,008  Caspase 9 inhibitor
0,128  0,004  Anesthetic inhalation
0,211  0,089  Antiglaucomic
0,195  0,075  Non-steroidal antiinflammatory agent
0,180  0,061  Toxic, respiratory center
0,136  0,018  Tourette's syndrome treatment
0,123  0,005  Liver X receptor agonist
0,185  0,067  Male reproductive disfunction treatment
0,162  0,044  Antifungal (Cryptococcus)
0,121  0,004  SULT2A1 substrate
0,137  0,020  SULT1E1 substrate
0,118  0,002  Glucose-6-phosphate dehydrogenase inhibitor
0,163  0,048  Skin whitener
0,189  0,074  Sepsis treatment
0,126  0,011  SULT1A2 substrate
0,135  0,021  Estrogen receptor beta antagonist
0,172  0,060  Uterine stimulant
0,116  0,005  Diacylglycerol O-acyltransferase inhibitor
0,206  0,095  Antineoplastic (lymphocytic leukemia)
0,168  0,057  NOS3 expression enhancer
0,177  0,066  Antineoplastic (bone cancer)
0,119  0,010  Phosphorylase inhibitor
0,115  0,009  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,205  0,100  Antihypotensive
0,108  0,003  Parathyroid hormone antagonist
0,107  0,004  Heparanase inhibitor
0,139  0,039  Constipation treatment
0,136  0,039  HDL-cholesterol increasing
0,209  0,112  Spasmolytic
0,200  0,105  Vasodilator
0,099  0,006  Postcoital contraceptive
0,123  0,033  Posttraumatic stress disorder treatment
0,159  0,070  Melanin inhibitor
0,177  0,089  CYP2B6 inhibitor
0,142  0,054  Antihemorrhagic
0,112  0,024  Keratolytic
0,239  0,152  Ulceration
0,153  0,067  Lipid peroxidase inhibitor
0,138  0,053  Adenylate cyclase inhibitor
0,096  0,012  Glutamate (mGluR6) antagonist
0,133  0,050  Menstruation disorders treatment
0,122  0,041  Toll-Like receptor 4 antagonist
0,084  0,003  HMG CoA reductase inhibitor
0,088  0,008  Acetyl-CoA transferase 2 inhibitor
0,089  0,009  Mineralocorticoid receptor antagonist
0,135  0,057  Vanilloid 1 agonist
0,090  0,016  Prostaglandin F2 alpha antagonist
0,132  0,057  Cell adhesion inhibitor
0,094  0,021  GABA B receptor agonist
0,174  0,102  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,134  0,063  Cyclooxygenase 3 inhibitor
0,103  0,034  Inducible nitric-oxide synthase inhibitor
0,080  0,011  Aldosterone antagonist
0,106  0,038  Antispirochetal
0,131  0,064  Carcinogenic, group 3
0,085  0,018  Nitric oxide donor
0,149  0,083  Thrombolytic
0,096  0,031  Estrogen-related receptor beta agonist
0,152  0,088  Muscular dystrophy treatment
0,079  0,014  Estrogen receptor beta agonist
0,092  0,028  Premenstrual syndrome treatment
0,169  0,105  Interleukin antagonist
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,116  0,053  GABA C receptor agonist
0,075  0,013  Estrogen receptor alpha agonist
0,063  0,004  CYP24 inhibitor
0,087  0,028  Antitreponemal
0,090  0,032  Selectin antagonist
0,175  0,117  Antiprotozoal (Leishmania)
0,067  0,009  GABA B receptor antagonist
0,094  0,037  Antibiotic
0,061  0,004  Ceramide glucosyltransferase inhibitor
0,101  0,044  Ornithine decarboxylase inhibitor
0,085  0,029  HIV-1 integrase (Strand Transfer) inhibitor
0,063  0,009  GABA uptake inhibitor
0,091  0,036  T cell inhibitor
0,074  0,020  Heme oxygenase stimulant
0,118  0,067  Proteasome inhibitor
0,064  0,012  AICAR transformylase inhibitor
0,219  0,167  GST A substrate
0,062  0,012  Microtubule stabilization
0,180  0,129  Peptidyltransferase inhibitor
0,072  0,025  GABA receptor antagonist
0,070  0,024  Acetyl-CoA transferase inhibitor
0,186  0,140  Antituberculosic
0,197  0,153  Antimycobacterial
0,053  0,010  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,064  0,023  Pregnane X receptor antagonist
0,051  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,044  0,004  Corticosteroid-like
0,045  0,005  Glucocorticoid agonist
0,098  0,058  Interleukin 12 antagonist
0,056  0,016  Geranyltranstransferase inhibitor
0,042  0,005  Prostaglandin F2 alpha agonist
0,141  0,104  Antiviral (Hepatitis C)
0,068  0,031  Carbonic anhydrase II inhibitor
0,145  0,110  ATPase inhibitor
0,116  0,081  Alpha-N-acetylglucosaminidase inhibitor
0,043  0,008  Glutamate (mGluR3) agonist
0,240  0,208  Antiarthritic
0,049  0,017  Hypogonadism treatment
0,067  0,036  Antimycoplasmal
0,042  0,011  Prostaglandin D2 agonist
0,070  0,040  Andropause treatment
0,248  0,218  Alzheimer's disease treatment
0,033  0,004  Sodium/hydrogen exchanger 3 inhibitor
0,031  0,003  Thromboxane A2 agonist
0,105  0,078  TRPA1 agonist
0,030  0,003  Thromboxane agonist
0,078  0,051  Narcotic antagonist
0,060  0,035  Carbonic anhydrase I inhibitor
0,116  0,092  Cocaine dependence treatment
0,047  0,026  Opioid kappa receptor agonist
0,142  0,120  Antihelmintic
0,055  0,035  GABA A receptor antagonist
0,025  0,004  Telomerase stimulant
0,050  0,030  Glucose-6-phosphate isomerase inhibitor
0,085  0,066  Triose-phosphate isomerase inhibitor
0,020  0,001  Transcortin receptor antagonist
0,026  0,008  Progesterone agonist
0,067  0,050  Phosphofructokinase-1 inhibitor
0,054  0,036  Protein 50S ribosomal subunit inhibitor
0,035  0,018  Carboxypeptidase B inhibitor
0,098  0,081  Chelator
0,020  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,039  0,022  Glutamate (mGluR3) antagonist
0,024  0,007  Prostacyclin agonist
0,061  0,045  Carbonic anhydrase inhibitor
0,034  0,018  Prostaglandin agonist
0,080  0,064  GABA A receptor agonist
0,036  0,021  Tubulin agonist
0,059  0,044  Carbamoyl phosphate synthetase inhibitor
0,021  0,007  Thyroid hormone alpha antagonist
0,033  0,020  ATP citrate lysase inhibitor
0,120  0,107  SULT1A3 substrate
0,158  0,148  Acute neurologic disorders treatment
0,087  0,080  Glutathione S-transferase substrate
0,043  0,037  Antimetabolite
0,008  0,002  Vitamin D-like
0,021  0,017  GRP78 expression inhibitor
0,031  0,027  Liver X receptor beta agonist
0,021  0,017  Prostaglandin EP2 agonist
0,037  0,035  Acetyl-CoA transferase 1 inhibitor
0,028  0,027  Cholesterol ester transfer protein antagonist
0,016  0,016  Sodium/hydrogen exchanger inhibitor
0,041  0,041  Potassium channel Kv1.3 blocker

